Latest News

07.19.18

Foundation Fighting Blindness Urges Congress to Pass ‘Eye-Bonds’ Legislation

Source: Foundation Fighting Blindness

07.19.18

Researchers Take Step Closer to Developing AMD Eye Drops

Source: University of Birmingham

07.19.18

Allergan and Molecular Partners Announce Positive Phase 3 Clinical Trials for Abicipar Pegol for the Treatment of Wet AMD

Source: Allergan

07.19.18

Ocular Therapeutix Announces FDA Acceptance of NDA Resubmission for Dextenza

Source: Ocular Therapeutix

07.19.18

FDA Releases Action Plan to Speed Up Market Entry for Biosimilars

Source: FirstWord

07.19.18

Bausch + Lomb Retina News, Events

Source: Bausch + Lomb

07.18.18

The Foundation Fighting Blindness Presents the Emerging Science Showcase at OIS Retina 2018

Source: Foundation Fighting Blindness

07.18.18

Alzheimer’s Therapeutics Research Leader Dr. Roy Twyman Joins NeuroVision Imaging Board

Source: NeuroVision

07.18.18

BlephEx Names Fred Ellis CEO

Source: Blephex

07.18.18

Sheraz Daya, MD, Introduces the Daya ICL Forceps

Source: MST

07.17.18

LensGen Announces Funding And Patent Success

Source: LensGen

07.17.18

RGN-259 (Tβ4) Improves Clinically Important Dry Eye Efficacies in Comparison with Prescription Drugs

Source: RegeneRx Biopharmaceuticals

07.16.18

OD-OS Achieves Revocation of Iridex MicroPulse Patent

Source: OD-OS

07.16.18

Practice-Hospital Consolidation Increasing for Many Specialties

Source: Medscape

07.16.18

Novartis Disputes Findings of Report From US Senators Claiming More Extensive Links With Trump Lawyer

Source: FirstWord

View more stories